Pharmacy-Based Atrial Fibrillation Screening Model Coordinated by a Regional Stroke and Cardiovascular Disease Support Center ― The Catch AF Project ―
Background: Atrial fibrillation (AF) is a major cause of cardioembolic stroke and often remains undiagnosed because of its asymptomatic or paroxysmal nature. Although opportunistic AF screening has been advocated, sustainable community-based screening models that link the results to medical evaluations are limited. We implemented a pharmacy-based AF screening initiative (Catch AF project) led by a regional Stroke and Cardiovascular Disease Support Center with community pharmacists and physicians to assess its feasibility and follow-up outcomes.
Authors
- Satoshi Ikeda (ORCID: https://orcid.org/0000-0001-8163-8038)
- Akira Tsujino
- Yohei Tateishi (ORCID: https://orcid.org/0000-0002-7685-6396)
- Mana Miyakoda
- Kaname Ohyama (ORCID: https://orcid.org/0000-0002-1449-5505)
- Masaya Kurobe (ORCID: https://orcid.org/0009-0007-0784-562X)
- Toshiaki Sakamoto (ORCID: https://orcid.org/0009-0005-6347-7935)
- Yukinobu Kodama
- Koji Maemura
- Hiroki Yahata
Institutions
- Chinese Pharmaceutical Association (CN)
- Nagasaki Prefectural Shimabara High School (JP)
- Nagasaki University Hospital (JP)
- Nagasaki University (JP)
Publication Details
- Journal
- Circulation Reports
- Published
- 2026-05-27
- DOI
- https://doi.org/10.1253/circrep.cr-26-0109
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Omron Healthcare